We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Hematologic Malignancies Program

University Hospitals Seidman Cancer Center

Brenda Cooper, MD, Disease Team Leader, Medical Oncology 216-844-3213, Brenda.Cooper@UHhospitals.org

For hospital transfers, please call 216-844-1111.

Conditions Treated

  • Leukemia
    Acute lymphoblastic leukemia
    Acute myeloid leukemia
    Chronic lymphocytic leukemia
    Chronic myelogenous leukemia
  • Lymphomas
    Non-Hodgkin lymphoma
    Hodgkin lymphoma
    Primary CNS lymphoma
  • Myeloma
  • Marrow failure syndromes


  • Stem cell transplantation and other novel cellular therapies
  • Biological therapy
  • Radiation therapy
  • Chemotherapy

Distinguishing Features

  • Part of NCI-designated Case Comprehensive Cancer Center
  • Accredited by the Foundation for the Accreditation of Cellular Therapy
  • Partner with National Center for Stem Cell and Regenerative Medicine to study and develop new stem cell-based therapies
  • Stem Cell Transplant Clinical Trials Network member
  • University Hospitals Rainbow Babies & Children’s Hospital member of the Pediatric Blood and Stem Cell Transplant Consortium
  • Specialized Adolescent and Young Adult (AYA) cancer program
  • Extensive portfolio of clinical trials of new treatments